139 related articles for article (PubMed ID: 31015814)
1. Updated NACI recommendations for measles post-exposure prophylaxis.
Tunis MC; Salvadori MI; Dubey V; Baclic O;
Can Commun Dis Rep; 2018 Sep; 44(9):226-230. PubMed ID: 31015814
[TBL] [Abstract][Full Text] [Related]
2. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Measles Vaccination and Immune Globulin Post-Exposure Prophylaxis in an Outbreak Setting-New York City, 2013.
Arciuolo RJ; Jablonski RR; Zucker JR; Rosen JB
Clin Infect Dis; 2017 Nov; 65(11):1843-1847. PubMed ID: 29028959
[TBL] [Abstract][Full Text] [Related]
4. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
[TBL] [Abstract][Full Text] [Related]
5. Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany.
Matysiak-Klose D; Santibanez S; Schwerdtfeger C; Koch J; von Bernuth H; Hengel H; Littmann M; Terhardt M; Wicker S; Mankertz A; Heininger U
Vaccine; 2018 Dec; 36(52):7916-7922. PubMed ID: 30478003
[TBL] [Abstract][Full Text] [Related]
6. Summary of the National Advisory Committee on Immunization (NACI) Statement Update on the Recommended Use of Hepatitis A Vaccine.
Henry B; Baclic O;
Can Commun Dis Rep; 2016 Sep; 42(9):193-194. PubMed ID: 29770031
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of an Intravenous Immune Globulin (IVIG) Preparation in Post-exposure Prophylaxis (PEP) Against Measles in Infants.
Kohlmaier B; Holzmann H; Stiasny K; Leitner M; Zurl C; Strenger V; Kundi M; Zenz W
Front Pediatr; 2021; 9():762793. PubMed ID: 34926346
[No Abstract] [Full Text] [Related]
8. Summary of the NACI Update on Herpes Zoster Vaccines.
Warrington R; Ismail S;
Can Commun Dis Rep; 2018 Sep; 44(9):220-225. PubMed ID: 31015813
[TBL] [Abstract][Full Text] [Related]
9. Estimated protective effectiveness of intramuscular immune serum globulin post-exposure prophylaxis during a measles outbreak in British Columbia, Canada, 2014.
Bigham M; Murti M; Fung C; Hemming F; Loadman S; Stam R; Van Buynder P; Lem M
Vaccine; 2017 May; 35(20):2723-2727. PubMed ID: 28392140
[TBL] [Abstract][Full Text] [Related]
10. Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel.
Nelson NP; Link-Gelles R; Hofmeister MG; Romero JR; Moore KL; Ward JW; Schillie SF
MMWR Morb Mortal Wkly Rep; 2018 Nov; 67(43):1216-1220. PubMed ID: 30383742
[TBL] [Abstract][Full Text] [Related]
11. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Güris D; Chaves SS; Schmid S; Seward JF;
MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291
[TBL] [Abstract][Full Text] [Related]
12. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2022-2023.
Sinilaite A; Papenburg J
Can Commun Dis Rep; 2022 Sep; 48(9):373-382. PubMed ID: 38116046
[TBL] [Abstract][Full Text] [Related]
13. Summary of the NACI Update on the recommended use of Human Papillomavirus (HPV) vaccine: Nine-valent HPV vaccine two-dose immunization schedule and the use of HPV vaccines in immunocompromised populations.
Deeks SL; Tunis MC; Ismail S;
Can Commun Dis Rep; 2017 Jun; 43(6):138-142. PubMed ID: 29770079
[TBL] [Abstract][Full Text] [Related]
14. Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule.
Tunis MC; Deeks SL;
Can Commun Dis Rep; 2016 Jul; 42(7):149-151. PubMed ID: 29770021
[TBL] [Abstract][Full Text] [Related]
15. Summary of the National Advisory Committee on Immunization (NACI) Rapid Response-Interim guidance on the use of Imvamune in the context of monkeypox outbreaks in Canada.
Killikelly A; Brousseau N
Can Commun Dis Rep; 2022 Jul; 48(7-8):367-371. PubMed ID: 37426289
[TBL] [Abstract][Full Text] [Related]
16. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
[TBL] [Abstract][Full Text] [Related]
17. Summary of the NACI Seasonal Influenza Vaccine Statement for 2020-2021.
Young K; Gemmill I; Harrison R
Can Commun Dis Rep; 2020 May; 46(5):132-137. PubMed ID: 32558810
[TBL] [Abstract][Full Text] [Related]
18. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2021-2022.
Can Commun Dis Rep; 2021 Sep; 47(9):372-380. PubMed ID: 34650334
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
[TBL] [Abstract][Full Text] [Related]
20. Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2016-2017.
Gemmill I; Zhao L; Cochrane L;
Can Commun Dis Rep; 2016 Sep; 42(9):188-192. PubMed ID: 29770030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
